Clinical PET Cast » Podcasts http://www.clinicalpetcast.com Peter Faulhaber, MD Fri, 27 Jan 2012 23:10:24 +0000 en hourly 1 http://wordpress.org/?v=3.1.4 Copyright © & Trademark 2009-2011 by Peter Faulhaber, MD clinicalpetcast@gmail.com (Peter Faulhaber, MD) clinicalpetcast@gmail.com (Peter Faulhaber, MD) Science and Medicine 1440 http://www.clinicalpetcast.com/wp-content/images/petcast_v6_144x144.jpg Clinical PET Cast http://www.clinicalpetcast.com 144 144 Feedback: clinicalpetcast@gmail.com or call (216) 455-0777 Clinical PET Cast is an educational resource for radiologists and other medical professionals regarding PET imaging. Peter Faulhaber is director of Clinical PET at University Hospitals Case Medical Center and Associate Professor of Radiology at Case Western Reserve University in Cleveland, Ohio. He is a leader in clinical PET with 30 years of experience in the field. The focus of this program is to increase knowledge in the clinical applications and principles of PET imaging. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD Peter Faulhaber, MD clinicalpetcast@gmail.com no no CPC-040 Head & Neck Cancer http://www.clinicalpetcast.com/2012/01/27/cpc-040-head-neck-cancer/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-040-head-neck-cancer http://www.clinicalpetcast.com/2012/01/27/cpc-040-head-neck-cancer/#comments Fri, 27 Jan 2012 23:10:24 +0000 DirtyD http://www.clinicalpetcast.com/?p=147 In this episode, I’m going to discuss head and neck cancer, including normal variations, clinical indications, and my favorite topic, radiation therapy planning with PET. Head and neck cancer is not as common as other cancers, but the high morbidity and mortality rates make it an important topic. I’ll also discuss the patient preparation and overall procedure used at our site with head and neck cases.

]]> http://www.clinicalpetcast.com/2012/01/27/cpc-040-head-neck-cancer/feed/ 0 0:12:47 In this episode, I’m going to discuss head and neck cancer, including normal variations, clinical indications, and my favorite topic, radiation therapy planning with PET. Head and neck cancer is not as common as other cancers, but the high mor[...] In this episode, I’m going to discuss head and neck cancer, including normal variations, clinical indications, and my favorite topic, radiation therapy planning with PET. Head and neck cancer is not as common as other cancers, but the high morbidity and mortality rates make it an important topic. I’ll also discuss the patient preparation and overall procedure used at our site with head and neck cases. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-039 Lung Cancer, Radiation Therapy & PET http://www.clinicalpetcast.com/2012/01/13/cpc-039-%e2%80%93-lung-cancer-radiation-therapy-pet/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-039-%25e2%2580%2593-lung-cancer-radiation-therapy-pet http://www.clinicalpetcast.com/2012/01/13/cpc-039-%e2%80%93-lung-cancer-radiation-therapy-pet/#comments Fri, 13 Jan 2012 23:00:08 +0000 DirtyD http://www.clinicalpetcast.com/?p=143 As we continue our discussion of lung cancer, I want to cover how radiation therapy and PET are becoming linked. I’ll discuss the three key volumes used for any plan, the most important of which is the Gross Tumor Volume (GTV) that the therapist delineates using imaging. In lung cancer, PET can have a particular influence on the size of the GTV, either by increasing or decreasing this volume. For example, PET can detect regional lymph nodes in non-small cell lung cancer patients.

]]> http://www.clinicalpetcast.com/2012/01/13/cpc-039-%e2%80%93-lung-cancer-radiation-therapy-pet/feed/ 0 0:10:02 As we continue our discussion of lung cancer, I want to cover how radiation therapy and PET are becoming linked. I’ll discuss the three key volumes used for any plan, the most important of which is the Gross Tumor Volume (GTV) that the therapi[...] As we continue our discussion of lung cancer, I want to cover how radiation therapy and PET are becoming linked. I’ll discuss the three key volumes used for any plan, the most important of which is the Gross Tumor Volume (GTV) that the therapist delineates using imaging. In lung cancer, PET can have a particular influence on the size of the GTV, either by increasing or decreasing this volume. For example, PET can detect regional lymph nodes in non-small cell lung cancer patients. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-038 Lung Cancer Staging http://www.clinicalpetcast.com/2011/12/09/cpc-038-lung-cancer-staging/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-038-lung-cancer-staging http://www.clinicalpetcast.com/2011/12/09/cpc-038-lung-cancer-staging/#comments Fri, 09 Dec 2011 23:05:05 +0000 DirtyD http://www.clinicalpetcast.com/?p=142 Today I’m going to continue my discussion of PET and lung cancer by going through a number of interesting studies. I’ve spoken before about the pitfalls of SUV, but there is research that shows that the SUV combined with Hounsfield units can be very helpful when studying adrenal lesions. Due to a lack of standardized criteria, it is difficult to completely quantify PET’s ability to help categorize patient response, yet the data shows that PET is very useful in therapy response and predicting patient survival.

 

]]> http://www.clinicalpetcast.com/2011/12/09/cpc-038-lung-cancer-staging/feed/ 0 0:12:22 Today I’m going to continue my discussion of PET and lung cancer by going through a number of interesting studies. I’ve spoken before about the pitfalls of SUV, but there is research that shows that the SUV combined with Hounsfield units[...] Today I’m going to continue my discussion of PET and lung cancer by going through a number of interesting studies. I’ve spoken before about the pitfalls of SUV, but there is research that shows that the SUV combined with Hounsfield units can be very helpful when studying adrenal lesions. Due to a lack of standardized criteria, it is difficult to completely quantify PET’s ability to help categorize patient response, yet the data shows that PET is very useful in therapy response and predicting patient survival.   radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-037 Lung Cancer and SUV Pitfalls http://www.clinicalpetcast.com/2011/12/03/cpc-037-lung-cancer-and-suv-pitfalls/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-037-lung-cancer-and-suv-pitfalls http://www.clinicalpetcast.com/2011/12/03/cpc-037-lung-cancer-and-suv-pitfalls/#comments Sat, 03 Dec 2011 21:05:56 +0000 DirtyD http://www.clinicalpetcast.com/?p=140 Today I’ll continue my discussion of PET and lung cancer. The SUV can be a valuable tool to use as a baseline and for follow-up, but essentially an SUV measurement on its own isn’t really better than visual analysis. I’ll discuss the various pitfalls of SUV, as well as tips for examining both solitary pulmonary nodules and the mediastinum.

]]> http://www.clinicalpetcast.com/2011/12/03/cpc-037-lung-cancer-and-suv-pitfalls/feed/ 0 0:11:44 Today I’ll continue my discussion of PET and lung cancer. The SUV can be a valuable tool to use as a baseline and for follow-up, but essentially an SUV measurement on its own isn’t really better than visual analysis. I’ll discuss t[...] Today I’ll continue my discussion of PET and lung cancer. The SUV can be a valuable tool to use as a baseline and for follow-up, but essentially an SUV measurement on its own isn’t really better than visual analysis. I’ll discuss the various pitfalls of SUV, as well as tips for examining both solitary pulmonary nodules and the mediastinum. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-036 Lung Cancer and PET http://www.clinicalpetcast.com/2011/11/11/cpc-036-lung-cancer-and-pet/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-036-lung-cancer-and-pet http://www.clinicalpetcast.com/2011/11/11/cpc-036-lung-cancer-and-pet/#comments Fri, 11 Nov 2011 21:32:16 +0000 DirtyD http://www.clinicalpetcast.com/?p=137 In this episode, I will discuss the history of approved reimbursements from CMS, from the 1998 approval for solitary pulmonary nodules to more recent changes in terminology that affect our billing.  Lung cancer has a high mortality rate in both men and women, and the current statistics on the subject are striking.  I will also go into detail about how our site uses PET with lung cancer cases.

]]> http://www.clinicalpetcast.com/2011/11/11/cpc-036-lung-cancer-and-pet/feed/ 0 0:12:17 In this episode, I will discuss the history of approved reimbursements from CMS, from the 1998 approval for solitary pulmonary nodules to more recent changes in terminology that affect our billing.  Lung cancer has a high mortality rate in both men[...] In this episode, I will discuss the history of approved reimbursements from CMS, from the 1998 approval for solitary pulmonary nodules to more recent changes in terminology that affect our billing.  Lung cancer has a high mortality rate in both men and women, and the current statistics on the subject are striking.  I will also go into detail about how our site uses PET with lung cancer cases. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-035 Pediatric PET, Disease States http://www.clinicalpetcast.com/2011/10/28/cpc-035-pediatric-pet-disease-states/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-035-pediatric-pet-disease-states http://www.clinicalpetcast.com/2011/10/28/cpc-035-pediatric-pet-disease-states/#comments Fri, 28 Oct 2011 20:47:32 +0000 DirtyD http://www.clinicalpetcast.com/?p=134 In this follow-up to Pediatric PET, I’ll move to discussing specific applications and disease states. In pediatrics, it is particularly important to minimize dose, since the patient will hopefully have many more years to live. I’ll talk about how standalone PET, and the new developments in PET/MR, can potentially help reduce the frequency of using diagnostic CT.

]]> http://www.clinicalpetcast.com/2011/10/28/cpc-035-pediatric-pet-disease-states/feed/ 0 0:11:21 In this follow-up to Pediatric PET, I’ll move to discussing specific applications and disease states. In pediatrics, it is particularly important to minimize dose, since the patient will hopefully have many more years to live. I’ll talk [...] In this follow-up to Pediatric PET, I’ll move to discussing specific applications and disease states. In pediatrics, it is particularly important to minimize dose, since the patient will hopefully have many more years to live. I’ll talk about how standalone PET, and the new developments in PET/MR, can potentially help reduce the frequency of using diagnostic CT. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-034 Pediatric PET, Patient Considerations http://www.clinicalpetcast.com/2011/10/14/cpc-034-pediatric-pet-patient-considerations/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-034-pediatric-pet-patient-considerations http://www.clinicalpetcast.com/2011/10/14/cpc-034-pediatric-pet-patient-considerations/#comments Fri, 14 Oct 2011 21:25:56 +0000 DirtyD http://www.clinicalpetcast.com/?p=133 Today I want to talk about pediatric PET, and the issues we encounter before any images even get to the radiologist.  It may sound simplistic, but children are not little adults, and often patient sedation is required.  Because of this, it’s best to coordinate exams close to each other in time, and in the same room if possible.  Overall, we want to minimize sedation time, dose, delays between scans, and patient discomfort.  And of course, don’t forget about the parents!

]]> http://www.clinicalpetcast.com/2011/10/14/cpc-034-pediatric-pet-patient-considerations/feed/ 0 0:11:37 Today I want to talk about pediatric PET, and the issues we encounter before any images even get to the radiologist.  It may sound simplistic, but children are not little adults, and often patient sedation is required.  Because of this, it’s[...] Today I want to talk about pediatric PET, and the issues we encounter before any images even get to the radiologist.  It may sound simplistic, but children are not little adults, and often patient sedation is required.  Because of this, it’s best to coordinate exams close to each other in time, and in the same room if possible.  Overall, we want to minimize sedation time, dose, delays between scans, and patient discomfort.  And of course, don’t forget about the parents! radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-033 Fusion, SPECT/CT and the Future http://www.clinicalpetcast.com/2011/10/07/cpc-033-fusion-spectct-and-the-future/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-033-fusion-spectct-and-the-future http://www.clinicalpetcast.com/2011/10/07/cpc-033-fusion-spectct-and-the-future/#comments Fri, 07 Oct 2011 21:34:51 +0000 DirtyD http://www.clinicalpetcast.com/?p=131 In this third look at fusing anatomic and physiological data, I want to examine why SPECT/CT has not enjoyed the popularity of PET/CT.  SPECT/CT can offer many of the same benefits as PET/CT, such as improved image quality, and it has some interesting brachytherapy applications,  Later in this podcast, I will also examine the future of PET/MR.

]]> http://www.clinicalpetcast.com/2011/10/07/cpc-033-fusion-spectct-and-the-future/feed/ 0 0:12:00 In this third look at fusing anatomic and physiological data, I want to examine why SPECT/CT has not enjoyed the popularity of PET/CT.  SPECT/CT can offer many of the same benefits as PET/CT, such as improved image quality, and it has some interest[...] In this third look at fusing anatomic and physiological data, I want to examine why SPECT/CT has not enjoyed the popularity of PET/CT.  SPECT/CT can offer many of the same benefits as PET/CT, such as improved image quality, and it has some interesting brachytherapy applications,  Later in this podcast, I will also examine the future of PET/MR. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-032 Fusion, the PET/CT Advancement http://www.clinicalpetcast.com/2011/08/15/cpc-032-fusion-the-petct-advancement/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-032-fusion-the-petct-advancement http://www.clinicalpetcast.com/2011/08/15/cpc-032-fusion-the-petct-advancement/#comments Mon, 15 Aug 2011 19:28:50 +0000 DirtyD http://www.clinicalpetcast.com/?p=128 In this episode, I continue my discussion of the advancements made by hardware fusion. The adoption of the combined PET/CT instrument gave us dramatic decreases in imaging time, reduced dose, and most importantly, gains in image quality. Even with these advancements, software fusion remains important for the future, since it allows comparison of images from different time points.

]]> http://www.clinicalpetcast.com/2011/08/15/cpc-032-fusion-the-petct-advancement/feed/ 0 0:13:26 In this episode, I continue my discussion of the advancements made by hardware fusion. The adoption of the combined PET/CT instrument gave us dramatic decreases in imaging time, reduced dose, and most importantly, gains in image quality. Even with[...] In this episode, I continue my discussion of the advancements made by hardware fusion. The adoption of the combined PET/CT instrument gave us dramatic decreases in imaging time, reduced dose, and most importantly, gains in image quality. Even with these advancements, software fusion remains important for the future, since it allows comparison of images from different time points. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-031 Fusion, Essential to Patient Care http://www.clinicalpetcast.com/2011/07/01/cpc-031-fusion-essential-to-patient-care/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-031-fusion-essential-to-patient-care http://www.clinicalpetcast.com/2011/07/01/cpc-031-fusion-essential-to-patient-care/#comments Fri, 01 Jul 2011 22:47:24 +0000 DirtyD http://www.clinicalpetcast.com/?p=123 We’ve already benefited a great deal from fusion thanks to the clinical context it provides for surgery and radiation therapy.  In this episode, I’m going to discuss both software and hardware fusion and the advancements made by these techniques.  Software techniques have improved with deformable registration, and the combined instrument in hardware is really very useful for improving image quality.

]]> http://www.clinicalpetcast.com/2011/07/01/cpc-031-fusion-essential-to-patient-care/feed/ 0 0:12:01 We’ve already benefited a great deal from fusion thanks to the clinical context it provides for surgery and radiation therapy.  In this episode, I’m going to discuss both software and hardware fusion and the advancements made by these t[...] We’ve already benefited a great deal from fusion thanks to the clinical context it provides for surgery and radiation therapy.  In this episode, I’m going to discuss both software and hardware fusion and the advancements made by these techniques.  Software techniques have improved with deformable registration, and the combined instrument in hardware is really very useful for improving image quality. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-030 Technologists http://www.clinicalpetcast.com/2011/06/16/cpc-030-technologists/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-030-technologists http://www.clinicalpetcast.com/2011/06/16/cpc-030-technologists/#comments Thu, 16 Jun 2011 21:43:06 +0000 DirtyD http://www.clinicalpetcast.com/?p=121 A good technologist can really be an important asset in a PET/CT department like ours.  A great technologist should first and foremost reduce patient anxiety, but in this episode I’ll also talk about how a careful and educated technologist is needed to get both complete and accurate images.

]]> http://www.clinicalpetcast.com/2011/06/16/cpc-030-technologists/feed/ 1 0:09:41 A good technologist can really be an important asset in a PET/CT department like ours.  A great technologist should first and foremost reduce patient anxiety, but in this episode I’ll also talk about how a careful and educated technologist is[...] A good technologist can really be an important asset in a PET/CT department like ours.  A great technologist should first and foremost reduce patient anxiety, but in this episode I’ll also talk about how a careful and educated technologist is needed to get both complete and accurate images. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-029 The Radiologist in Radiotherapy Planning http://www.clinicalpetcast.com/2011/05/26/cpc-029-the-radiologist-in-radiotherapy-planning/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-029-the-radiologist-in-radiotherapy-planning http://www.clinicalpetcast.com/2011/05/26/cpc-029-the-radiologist-in-radiotherapy-planning/#comments Thu, 26 May 2011 13:45:15 +0000 DirtyD http://www.clinicalpetcast.com/?p=120 During radiotherapy treatment planning, communication between imaging experts and radiation therapists proves to be essential.  We as radiologists can help with the displayed image contrast and the different algorithms for segmentation.  The radiation therapy experts can tell us about when and how to measure the success of radiation therapy.  It turns out that therapeutic response can be measured a number of ways.

]]> http://www.clinicalpetcast.com/2011/05/26/cpc-029-the-radiologist-in-radiotherapy-planning/feed/ 0 0:14:46 During radiotherapy treatment planning, communication between imaging experts and radiation therapists proves to be essential.  We as radiologists can help with the displayed image contrast and the different algorithms for segmentation.  The radia[...] During radiotherapy treatment planning, communication between imaging experts and radiation therapists proves to be essential.  We as radiologists can help with the displayed image contrast and the different algorithms for segmentation.  The radiation therapy experts can tell us about when and how to measure the success of radiation therapy.  It turns out that therapeutic response can be measured a number of ways. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-028 Collaboration in Radiotherapy Planning http://www.clinicalpetcast.com/2011/05/13/cpc-028-%e2%80%93-collaboration-in-radiotherapy-planning/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-028-%25e2%2580%2593-collaboration-in-radiotherapy-planning http://www.clinicalpetcast.com/2011/05/13/cpc-028-%e2%80%93-collaboration-in-radiotherapy-planning/#comments Fri, 13 May 2011 22:32:09 +0000 DirtyD http://www.clinicalpetcast.com/?p=118 A recent talk I presented had me further examining how clinicians, radiologists, and radiation therapists interact during the treatment planning process.  I’ll illustrate with a prostate treatment example and later touch on the importance of image quality as it relates to SPECT and PET.  A healthy collaboration is essential to maximizing treatment dose, sparing normal tissues, and increasing the chances of a positive outcome.

]]> http://www.clinicalpetcast.com/2011/05/13/cpc-028-%e2%80%93-collaboration-in-radiotherapy-planning/feed/ 0 0:12:18 A recent talk I presented had me further examining how clinicians, radiologists, and radiation therapists interact during the treatment planning process.  I’ll illustrate with a prostate treatment example and later touch on the importance of [...] A recent talk I presented had me further examining how clinicians, radiologists, and radiation therapists interact during the treatment planning process.  I’ll illustrate with a prostate treatment example and later touch on the importance of image quality as it relates to SPECT and PET.  A healthy collaboration is essential to maximizing treatment dose, sparing normal tissues, and increasing the chances of a positive outcome. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-027 SNM 2010 – Radiopharmaceuticals http://www.clinicalpetcast.com/2010/10/08/cpc-027-snm-2010-radiopharmaceuticals/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-027-snm-2010-radiopharmaceuticals http://www.clinicalpetcast.com/2010/10/08/cpc-027-snm-2010-radiopharmaceuticals/#comments Fri, 08 Oct 2010 19:00:17 +0000 DirtyD http://www.clinicalpetcast.com/?p=115 Dr. Faulhaber continues his thoughts on SNM 2010 with a review of radiopharmaceuticals. He then discusses trends in scanning instruments towards minimum dose, maximum speed, and increased image quality. Dr. Faulhaber also explores the improvements in imaging software and the exciting trend of server-based imaging using cloud technology.

]]> http://www.clinicalpetcast.com/2010/10/08/cpc-027-snm-2010-radiopharmaceuticals/feed/ 0 0:12:36 Dr. Faulhaber continues his thoughts on SNM 2010 with a review of radiopharmaceuticals. Dr. Faulhaber continues his thoughts on SNM 2010 with a review of radiopharmaceuticals. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-026 SNM 2010 – Cyclotrons http://www.clinicalpetcast.com/2010/09/17/cpc-026-snm-2010-cyclotrons/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-026-snm-2010-cyclotrons http://www.clinicalpetcast.com/2010/09/17/cpc-026-snm-2010-cyclotrons/#comments Fri, 17 Sep 2010 21:00:12 +0000 DirtyD http://www.clinicalpetcast.com/?p=112 Dr. Faulhaber reflects on his trip to SNM 2010 with some thoughts on the history and improvements in cyclotrons, noting that the current trend will help spread PET technology into smaller hospitals, especially in third world nations.

]]> http://www.clinicalpetcast.com/2010/09/17/cpc-026-snm-2010-cyclotrons/feed/ 0 0:09:19 Dr. Faulhaber reflects on his trip to SNM 2010 with some thoughts on the history and improvements in cyclotrons, noting that the current trend will help spread PET technology into smaller hospitals, especially in third world nations. Dr. Faulhaber reflects on his trip to SNM 2010 with some thoughts on the history and improvements in cyclotrons, noting that the current trend will help spread PET technology into smaller hospitals, especially in third world nations. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-025 Brain Imaging, Seizures http://www.clinicalpetcast.com/2010/05/14/cpc-025-brain-imaging-seizures/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-025-brain-imaging-seizures http://www.clinicalpetcast.com/2010/05/14/cpc-025-brain-imaging-seizures/#comments Fri, 14 May 2010 22:00:58 +0000 DirtyD http://www.clinicalpetcast.com/?p=106 Dr. Faulhaber concludes his three-part series on non-oncologic brain imaging by discussing refractory seizures. He covers the techniques for evaluating intractable epilepsy, including the role of PET in brain surgery guidance. Dr. Faulhaber also discusses why interictal PET combined with ictal and interictal SPECT will have a better chance of finding an epileptogenic focus. He then discusses the importance of co-registering these scans with software and using subtraction techniques.

]]> http://www.clinicalpetcast.com/2010/05/14/cpc-025-brain-imaging-seizures/feed/ 0 0:13:34 Dr. Faulhaber concludes his three-part series on non-oncologic brain imaging by discussing refractory seizures. He covers the techniques for evaluating intractable epilepsy, including the role of PET in brain surgery guidance. Dr. Faulhaber also dis[...] Dr. Faulhaber concludes his three-part series on non-oncologic brain imaging by discussing refractory seizures. He covers the techniques for evaluating intractable epilepsy, including the role of PET in brain surgery guidance. Dr. Faulhaber also discusses why interictal PET combined with ictal and interictal SPECT will have a better chance of finding an epileptogenic focus. He then discusses the importance of co-registering these scans with software and using subtraction techniques. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-024 Brain Imaging, Dementia http://www.clinicalpetcast.com/2010/05/07/cpc-024-brain-imaging-dementia/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-024-brain-imaging-dementia http://www.clinicalpetcast.com/2010/05/07/cpc-024-brain-imaging-dementia/#comments Fri, 07 May 2010 21:30:38 +0000 DirtyD http://www.clinicalpetcast.com/?p=103 Dr. Faulhaber continues his three-part series on non-oncologic brain imaging by covering a wide range of dementia. He examines the challenge of diagnosing from a broad spectrum of symptomatic criteria and looks at the dangers of treating one type of dementia as if it were another. Dr. Faulhaber concludes by examining the promising new agents being used for dementia PET imaging, which offer hope for more accurate diagnoses.

]]> http://www.clinicalpetcast.com/2010/05/07/cpc-024-brain-imaging-dementia/feed/ 0 0:10:27 Dr. Faulhaber continues his three-part series on non-oncologic brain imaging by covering a wide range of dementia. He examines the challenge of diagnosing from a broad spectrum of symptomatic criteria and looks at the dangers of treating one type of[...] Dr. Faulhaber continues his three-part series on non-oncologic brain imaging by covering a wide range of dementia. He examines the challenge of diagnosing from a broad spectrum of symptomatic criteria and looks at the dangers of treating one type of dementia as if it were another. Dr. Faulhaber concludes by examining the promising new agents being used for dementia PET imaging, which offer hope for more accurate diagnoses. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-023 Brain Imaging, Alzheimer’s http://www.clinicalpetcast.com/2010/04/30/cpc-023-brain-imaging-alzheimers-2/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-023-brain-imaging-alzheimers-2 http://www.clinicalpetcast.com/2010/04/30/cpc-023-brain-imaging-alzheimers-2/#comments Fri, 30 Apr 2010 21:30:21 +0000 DirtyD http://www.clinicalpetcast.com/?p=105 Dr. Faulhaber begins a three-part series on non-oncologic brain imaging. He summarizes the CMS approval process, which has led to the evaluation of Alzheimer’s Dementia (AD) with PET. He also examines how imaging can help aid in the early diagnosis and in distinguishing between AD and mild cognitive impairment. Early detection and treatment to delay the onset of AD could potentially have a significant impact on the cost of care, which is currently estimated at 150 billion dollars.

]]> http://www.clinicalpetcast.com/2010/04/30/cpc-023-brain-imaging-alzheimers-2/feed/ 0 0:13:15 Dr. Faulhaber begins a three-part series on non-oncologic brain imaging. He summarizes the CMS approval process, which has led to the evaluation of Alzheimer’s Dementia (AD) with PET. He also examines how imaging can help aid in the early d[...] Dr. Faulhaber begins a three-part series on non-oncologic brain imaging. He summarizes the CMS approval process, which has led to the evaluation of Alzheimer’s Dementia (AD) with PET. He also examines how imaging can help aid in the early diagnosis and in distinguishing between AD and mild cognitive impairment. Early detection and treatment to delay the onset of AD could potentially have a significant impact on the cost of care, which is currently estimated at 150 billion dollars. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-022 PET for Clinical Staff, Radiation Therapy http://www.clinicalpetcast.com/2010/04/23/cpc-022-pet-for-clinical-staff-radiation-therapy/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-022-pet-for-clinical-staff-radiation-therapy http://www.clinicalpetcast.com/2010/04/23/cpc-022-pet-for-clinical-staff-radiation-therapy/#comments Fri, 23 Apr 2010 21:31:34 +0000 DirtyD http://www.clinicalpetcast.com/?p=100 Dr. Faulhaber concludes his four-part series for clinical staff by looking at the challenges of radiation therapy. He emphasizes the extreme importance of clear communication among the various clinical teams in understanding the plan and possible treatment protocols. For example, using a flat versus a curved table can have a significant impact on the success of the radiation therapy. Dr. Faulhaber also examines the various methods of drawing PET tumor volumes, including constant threshold edge detection and the more accurate gradient edge detection.

]]> http://www.clinicalpetcast.com/2010/04/23/cpc-022-pet-for-clinical-staff-radiation-therapy/feed/ 0 0:12:50 Dr. Faulhaber concludes his four-part series for clinical staff by looking at the challenges of radiation therapy. Dr. Faulhaber concludes his four-part series for clinical staff by looking at the challenges of radiation therapy. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-021 PET for Clinical Staff, Physiologic Parameters http://www.clinicalpetcast.com/2010/04/16/cpc-021-pet-for-clinical-staff-physiologic-parameters/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-021-pet-for-clinical-staff-physiologic-parameters http://www.clinicalpetcast.com/2010/04/16/cpc-021-pet-for-clinical-staff-physiologic-parameters/#comments Fri, 16 Apr 2010 21:53:50 +0000 DirtyD http://www.clinicalpetcast.com/?p=99 Dr. Faulhaber continues his four-part series for the nurses, technologists, and physicians directly taking care of the patient. He describes the patient’s physiologic parameters that affect what lesions and tumors can and cannot be seen. He also discusses the value of respiratory gating to overcome blurring and the difficulties of minimizing errors when evaluating SUVs.

]]> http://www.clinicalpetcast.com/2010/04/16/cpc-021-pet-for-clinical-staff-physiologic-parameters/feed/ 0 0:12:49 Dr. Faulhaber continues his four-part series for the nurses, technologists, and physicians directly taking care of the patient. He describes the patient's physiologic parameters that affect what lesions and tumors can and cannot be seen. He also dis[...] Dr. Faulhaber continues his four-part series for the nurses, technologists, and physicians directly taking care of the patient. He describes the patient's physiologic parameters that affect what lesions and tumors can and cannot be seen. He also discusses the value of respiratory gating to overcome blurring and the difficulties of minimizing errors when evaluating SUVs. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-020 PET for Clinical Staff, Hardware & Exposure http://www.clinicalpetcast.com/2010/04/09/cpc-020-pet-for-clinical-staff-hardware-exposure/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-020-pet-for-clinical-staff-hardware-exposure http://www.clinicalpetcast.com/2010/04/09/cpc-020-pet-for-clinical-staff-hardware-exposure/#comments Fri, 09 Apr 2010 20:11:46 +0000 DirtyD http://www.clinicalpetcast.com/?p=97 Dr. Faulhaber continues his four-part series for the nurses, technologists, and physicians directly taking care of the patient. He describes many of the terms, mechanical functions, and time requirements involved in using a PET/CT scanner. Dr. Faulhaber also covers the potential exposure of patients and clinical staff to radiological dose.

]]> http://www.clinicalpetcast.com/2010/04/09/cpc-020-pet-for-clinical-staff-hardware-exposure/feed/ 0 0:12:39 Dr. Faulhaber continues his four-part series for the nurses, technologists, and physicians directly taking care of the patient. He describes many of the terms, mechanical functions, and time requirements involved in using a PET/CT scanner. Dr. Faulh[...] Dr. Faulhaber continues his four-part series for the nurses, technologists, and physicians directly taking care of the patient. He describes many of the terms, mechanical functions, and time requirements involved in using a PET/CT scanner. Dr. Faulhaber also covers the potential exposure of patients and clinical staff to radiological dose. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-019 PET for Clinical Staff, Positron Emitters http://www.clinicalpetcast.com/2010/04/02/cpc-019-pet-for-clinical-staff-positron-emitters/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-019-pet-for-clinical-staff-positron-emitters http://www.clinicalpetcast.com/2010/04/02/cpc-019-pet-for-clinical-staff-positron-emitters/#comments Fri, 02 Apr 2010 19:00:22 +0000 DirtyD http://www.clinicalpetcast.com/?p=95 Dr. Faulhaber begins a four-part series for the entire clinical staff–the nurses, technologists, and physicians directly taking care of the patient. Having some PET background is important, because the patient today is likely to be more sophisticated and educated about treatment and terminology. Dr. Faulhaber begins with an explanation of PET scanners and positron emitters.

]]> http://www.clinicalpetcast.com/2010/04/02/cpc-019-pet-for-clinical-staff-positron-emitters/feed/ 0 0:11:15 Dr. Faulhaber begins a four-part series for the entire clinical staff--the nurses, technologists, and physicians directly taking care of the patient. Having some PET background is important, because the patient today is likely to be more sophisticat[...] Dr. Faulhaber begins a four-part series for the entire clinical staff--the nurses, technologists, and physicians directly taking care of the patient. Having some PET background is important, because the patient today is likely to be more sophisticated and educated about treatment and terminology. Dr. Faulhaber begins with an explanation of PET scanners and positron emitters. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-018 Breast Cancer, Metastases http://www.clinicalpetcast.com/2010/03/26/cpc-018-breast-cancer-metastases/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-018-breast-cancer-metastases http://www.clinicalpetcast.com/2010/03/26/cpc-018-breast-cancer-metastases/#comments Fri, 26 Mar 2010 20:00:28 +0000 DirtyD http://www.clinicalpetcast.com/?p=94 Dr. Faulhaber concludes his two part series on breast cancer. He continues beyond using PET to see the primary, to evaluating axillary lymph node metastases and prognosis.

]]> http://www.clinicalpetcast.com/2010/03/26/cpc-018-breast-cancer-metastases/feed/ 0 0:15:15 Dr. Faulhaber concludes his two part series on breast cancer. He continues beyond using PET to see the primary, to evaluating axillary lymph node metastases and prognosis. Dr. Faulhaber concludes his two part series on breast cancer. He continues beyond using PET to see the primary, to evaluating axillary lymph node metastases and prognosis. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-017 Breast Cancer, Changes in Therapy http://www.clinicalpetcast.com/2010/03/19/cpc-017-breast-cancer-changes-in-therapy/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-017-breast-cancer-changes-in-therapy http://www.clinicalpetcast.com/2010/03/19/cpc-017-breast-cancer-changes-in-therapy/#comments Fri, 19 Mar 2010 21:22:30 +0000 DirtyD http://www.clinicalpetcast.com/?p=92 Dr. Faulhaber begins a two part series on PET/CT and breast cancer. PET can have a significant impact on the changes in therapy in conjunction with the availability of multiple chemo therapy regiments.

]]> http://www.clinicalpetcast.com/2010/03/19/cpc-017-breast-cancer-changes-in-therapy/feed/ 0 0:12:29 Dr. Faulhaber begins a two part series on PET/CT and breast cancer. PET can have a significant impact on the changes in therapy in conjunction with the availability of multiple chemo therapy regiments. Dr. Faulhaber begins a two part series on PET/CT and breast cancer. PET can have a significant impact on the changes in therapy in conjunction with the availability of multiple chemo therapy regiments. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-016 Uterine Malignancies http://www.clinicalpetcast.com/2010/03/12/cpc-016-uterine-malignancies/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-016-uterine-malignancies http://www.clinicalpetcast.com/2010/03/12/cpc-016-uterine-malignancies/#comments Fri, 12 Mar 2010 22:00:17 +0000 DirtyD http://www.clinicalpetcast.com/?p=90 Dr. Faulhaber concludes his three-part session on gynecologic oncology by examining various uterine malignancies and the disturbing fact that the incidence of cancer is increasing but is tempered by a high cure rate.

]]> http://www.clinicalpetcast.com/2010/03/12/cpc-016-uterine-malignancies/feed/ 0 0:14:13 Dr. Faulhaber concludes his three-part session on gynecologic oncology by examining various uterine malignancies and the disturbing fact that the incidence of cancer is increasing but is tempered by a high cure rate. Dr. Faulhaber concludes his three-part session on gynecologic oncology by examining various uterine malignancies and the disturbing fact that the incidence of cancer is increasing but is tempered by a high cure rate. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-015 Cervical Cancer http://www.clinicalpetcast.com/2010/03/05/cpc-015-cervical-cancer/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-015-cervical-cancer http://www.clinicalpetcast.com/2010/03/05/cpc-015-cervical-cancer/#comments Fri, 05 Mar 2010 22:29:02 +0000 DirtyD http://www.clinicalpetcast.com/?p=89 Dr. Faulhaber continues his three-part session on PET/CT and gynecologic oncology, specifically cervical cancer. The keys to cure include prevention with a vaccine, early detection, and accurate staging.

]]> http://www.clinicalpetcast.com/2010/03/05/cpc-015-cervical-cancer/feed/ 0 0:16:14 Dr. Faulhaber continues his three-part session on PET/CT and gynecologic oncology, specifically cervical cancer. The keys to cure include prevention with a vaccine, early detection, and accurate staging. Dr. Faulhaber continues his three-part session on PET/CT and gynecologic oncology, specifically cervical cancer. The keys to cure include prevention with a vaccine, early detection, and accurate staging. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-014 CMS and Gynecologic Oncology http://www.clinicalpetcast.com/2010/02/26/cpc-014-cms-and-gynecologic-oncology/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-014-cms-and-gynecologic-oncology http://www.clinicalpetcast.com/2010/02/26/cpc-014-cms-and-gynecologic-oncology/#comments Fri, 26 Feb 2010 20:45:12 +0000 DirtyD http://www.clinicalpetcast.com/?p=87 Dr. Faulhaber begins his three part series on PET/CT and gynecologic oncology by examining Medicare and Medicare Services and their recent decisions impacting gynecologic malignancies.

]]> http://www.clinicalpetcast.com/2010/02/26/cpc-014-cms-and-gynecologic-oncology/feed/ 0 0:12:43 Dr. Faulhaber begins his three part series on PET/CT and gynecologic oncology by examining Medicare and Medicare Services and their recent decisions impacting gynecologic malignancies. Dr. Faulhaber begins his three part series on PET/CT and gynecologic oncology by examining Medicare and Medicare Services and their recent decisions impacting gynecologic malignancies. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-013 Respiratory Gating Impact http://www.clinicalpetcast.com/2010/02/19/cpc-013-respiratory-gating-impact-pt2/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-013-respiratory-gating-impact-pt2 http://www.clinicalpetcast.com/2010/02/19/cpc-013-respiratory-gating-impact-pt2/#comments Fri, 19 Feb 2010 22:00:43 +0000 DirtyD http://www.clinicalpetcast.com/?p=86 Dr. Faulhaber continues his two-part session by examining the impact of respiratory gating on localization, quantification, correlation, and therapy planning.

]]> http://www.clinicalpetcast.com/2010/02/19/cpc-013-respiratory-gating-impact-pt2/feed/ 0 0:15:17 Dr. Faulhaber continues his two-part session by examining the impact of respiratory gating on localization, quantification, correlation, and therapy planning. Dr. Faulhaber continues his two-part session by examining the impact of respiratory gating on localization, quantification, correlation, and therapy planning. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-012 Respiratory Gating Techniques http://www.clinicalpetcast.com/2010/02/12/cpc-012-respiratory-gating-techniques-pt1/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-012-respiratory-gating-techniques-pt1 http://www.clinicalpetcast.com/2010/02/12/cpc-012-respiratory-gating-techniques-pt1/#comments Fri, 12 Feb 2010 22:03:18 +0000 DirtyD http://www.clinicalpetcast.com/?p=84 Dr. Faulhaber begins a two-part session by exploring, “Why bother doing respiratory gating?” and the refinements in PET in “stopping” the motion and seeing the lesion better.  He also discusses FDG and how imaging techniques have changed with improvements in hardware, software, and fusion.

]]> http://www.clinicalpetcast.com/2010/02/12/cpc-012-respiratory-gating-techniques-pt1/feed/ 0 0:13:01 Dr. Faulhaber begins a two-part session by exploring, "Why bother doing respiratory gating?" and the refinements in PET in "stopping" the motion and seeing the lesion better. He also discusses FDG and how imaging techniques have changed with improv[...] Dr. Faulhaber begins a two-part session by exploring, "Why bother doing respiratory gating?" and the refinements in PET in "stopping" the motion and seeing the lesion better. He also discusses FDG and how imaging techniques have changed with improvements in hardware, software, and fusion. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-011 Reporting http://www.clinicalpetcast.com/2010/02/05/cpc-011/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-011 http://www.clinicalpetcast.com/2010/02/05/cpc-011/#comments Fri, 05 Feb 2010 22:00:39 +0000 DirtyD http://www.clinicalpetcast.com/?p=82 Dr. Faulhaber explores what information (such as malignancy, grade, or previous treatment/surgery) should be specified when a clinician orders a PET, and what information (such as dose, glucose level, and type of scan) should be returned in the final PET report.

]]> http://www.clinicalpetcast.com/2010/02/05/cpc-011/feed/ 0 0:10:44 Dr. Faulhaber explores what information (such as malignancy, grade, or previous treatment/surgery) should be specified when a clinician orders a PET, and what information (such as dose, glucose level, and type of scan) should be returned in the fina[...] Dr. Faulhaber explores what information (such as malignancy, grade, or previous treatment/surgery) should be specified when a clinician orders a PET, and what information (such as dose, glucose level, and type of scan) should be returned in the final PET report. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-010 Imaging of Gastrointestinal Malignancies Pt3 http://www.clinicalpetcast.com/2010/01/29/cpc-010-imaging-of-gastrointestinal-malignancies-pt3/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-010-imaging-of-gastrointestinal-malignancies-pt3 http://www.clinicalpetcast.com/2010/01/29/cpc-010-imaging-of-gastrointestinal-malignancies-pt3/#comments Fri, 29 Jan 2010 21:10:49 +0000 DirtyD http://www.clinicalpetcast.com/?p=81 Dr. Faulhaber concludes his three part series on clinical indications by looking at diseases specific to the liver and gastrointestinal stromo tumors.

]]> http://www.clinicalpetcast.com/2010/01/29/cpc-010-imaging-of-gastrointestinal-malignancies-pt3/feed/ 0 0:14:52 Dr. Faulhaber concludes his three part series on clinical indications by looking at diseases specific to the liver and gastrointestinal stromo tumors. Dr. Faulhaber concludes his three part series on clinical indications by looking at diseases specific to the liver and gastrointestinal stromo tumors. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-009 Imaging of Gastrointestinal Malignancies Pt2 http://www.clinicalpetcast.com/2010/01/22/cpc-009-imaging-of-gastrointestinal-malignancies-pt2/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-009-imaging-of-gastrointestinal-malignancies-pt2 http://www.clinicalpetcast.com/2010/01/22/cpc-009-imaging-of-gastrointestinal-malignancies-pt2/#comments Fri, 22 Jan 2010 20:25:01 +0000 DirtyD http://www.clinicalpetcast.com/?p=79 Dr. Faulhaber continues his three-part series on clinical indications by looking at PET imaging of the abdomen and comparing treatment planning pre- and post-PET.

]]> http://www.clinicalpetcast.com/2010/01/22/cpc-009-imaging-of-gastrointestinal-malignancies-pt2/feed/ 0 0:15:11 Dr. Faulhaber continues his three-part series on clinical indications by looking at PET imaging of the abdomen and comparing treatment planning pre- and post-PET. Dr. Faulhaber continues his three-part series on clinical indications by looking at PET imaging of the abdomen and comparing treatment planning pre- and post-PET. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-008 Imaging of Gastrointestinal Malignancies Pt1 http://www.clinicalpetcast.com/2010/01/15/cpc-008-imaging-of-gastrointestinal-malignancies-pt1/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-008-imaging-of-gastrointestinal-malignancies-pt1 http://www.clinicalpetcast.com/2010/01/15/cpc-008-imaging-of-gastrointestinal-malignancies-pt1/#comments Fri, 15 Jan 2010 22:17:37 +0000 DirtyD http://www.clinicalpetcast.com/?p=78 Dr. Faulhaber begins his three part series on clinical indications by looking at diseases of the abdomen and pelvis, specifically colorectal cancer.

]]> http://www.clinicalpetcast.com/2010/01/15/cpc-008-imaging-of-gastrointestinal-malignancies-pt1/feed/ 0 0:14:37 Dr. Faulhaber begins his three part series on clinical indications by looking at diseases of the abdomen and pelvis, specifically colorectal cancer. Dr. Faulhaber begins his three part series on clinical indications by looking at diseases of the abdomen and pelvis, specifically colorectal cancer. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-007 From Prognosis to Treatment Planning http://www.clinicalpetcast.com/2010/01/08/cpc-007-from-prognosis-to-treatment-planning/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-007-from-prognosis-to-treatment-planning http://www.clinicalpetcast.com/2010/01/08/cpc-007-from-prognosis-to-treatment-planning/#comments Fri, 08 Jan 2010 20:56:13 +0000 DirtyD http://www.clinicalpetcast.com/?p=71 Dr. Faulhaber looks at the many advantages that image fusion, or PET/CT, has brought to PET, such as increased accuracy in the pinpointing of tumors.

]]> http://www.clinicalpetcast.com/2010/01/08/cpc-007-from-prognosis-to-treatment-planning/feed/ 0 0:13:01 Dr. Faulhaber looks at the many advantages that image fusion, or PET/CT, has brought to PET, such as increased accuracy in the pinpointing of tumors. Dr. Faulhaber looks at the many advantages that image fusion, or PET/CT, has brought to PET, such as increased accuracy in the pinpointing of tumors. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-006 Moving Beyond Staging & Restaging http://www.clinicalpetcast.com/2009/12/18/cpc-006-moving-beyond-staging-restaging/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-006-moving-beyond-staging-restaging http://www.clinicalpetcast.com/2009/12/18/cpc-006-moving-beyond-staging-restaging/#comments Fri, 18 Dec 2009 08:30:53 +0000 DirtyD http://www.clinicalpetcast.com/?p=69 Dr. Faulhaber continues with his discussion of the clinical use of PET. He discusses the usefulness of PET in determining the prognosis of a patient.

]]> http://www.clinicalpetcast.com/2009/12/18/cpc-006-moving-beyond-staging-restaging/feed/ 0 0:10:53 Dr. Faulhaber continues with his discussion of the clinical use of PET. He discusses the usefulness of PET in determining the prognosis of a patient. Dr. Faulhaber continues with his discussion of the clinical use of PET. He discusses the usefulness of PET in determining the prognosis of a patient. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-005 Clinical Indication for PET Approved by CMS http://www.clinicalpetcast.com/2009/12/11/cpc-005-clinical-indication-for-pet-approved-by-cms/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-005-clinical-indication-for-pet-approved-by-cms http://www.clinicalpetcast.com/2009/12/11/cpc-005-clinical-indication-for-pet-approved-by-cms/#comments Fri, 11 Dec 2009 22:05:39 +0000 DirtyD http://www.clinicalpetcast.com/?p=68 Dr. Faulhaber examines how PET has developed clinically as the approval process of CMS has increased.  He begins with a brief review of the value of PET over time and the impact of Fluorine-18 tagged with Glucose as a very powerful imaging agent.

]]> http://www.clinicalpetcast.com/2009/12/11/cpc-005-clinical-indication-for-pet-approved-by-cms/feed/ 0 0:15:14 Dr. Faulhaber examines how PET has developed clinically as the approval process of CMS has increased. He begins with a brief review of the value of PET over time and the impact of Fluorine-18 tagged with Glucose as a very powerful imaging agent. Dr. Faulhaber examines how PET has developed clinically as the approval process of CMS has increased. He begins with a brief review of the value of PET over time and the impact of Fluorine-18 tagged with Glucose as a very powerful imaging agent. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no Welcome to my Podcast http://www.clinicalpetcast.com/2009/12/08/welcome-to-my-podcast/?utm_source=rss&utm_medium=rss&utm_campaign=welcome-to-my-podcast http://www.clinicalpetcast.com/2009/12/08/welcome-to-my-podcast/#comments Tue, 08 Dec 2009 21:35:26 +0000 DirtyD http://www.clinicalpetcast.com/?p=66 The initial episodes of Clinical PET Cast have been well received.  Upcoming programs will cover such wide-ranging topics as:

  • Approval Process of CMS
  • Staging & Restaging
  • Treatment Planning
  • Gastrointestinal Malignancies
  • Respiratory Gating

In the future, I am hoping to expand CPC to include a video podcast companion.  Your feedback will help me direct these plans and to guide the current podcast into areas most relevant to our practices.  Either leave a voicemail at 216-455-0777 or email clinicalpetcast@gmail.com.

-Thanks for listening, Peter

]]> http://www.clinicalpetcast.com/2009/12/08/welcome-to-my-podcast/feed/ 0 CPC-004 Intro to Quantitation http://www.clinicalpetcast.com/2009/12/04/cpc-004-intro-to-quantitation/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-004-intro-to-quantitation http://www.clinicalpetcast.com/2009/12/04/cpc-004-intro-to-quantitation/#comments Fri, 04 Dec 2009 22:45:14 +0000 DirtyD http://www.clinicalpetcast.com/?p=67 Dr. Faulhaber discusses the concept of quantitation and in particular the Standard Uptake Value or SUV.  Clinical PET relies on semi-quantitative methods which are based on the data acquired from the patient, and how that data is corrected for attenuation.

]]> http://www.clinicalpetcast.com/2009/12/04/cpc-004-intro-to-quantitation/feed/ 0 0:13:09 Dr. Faulhaber discusses the concept of quantitation and in particular the Standard Uptake Value or SUV. Clinical PET relies on semi-quantitative methods which are based on the data acquired from the patient, and how that data is corrected for atte[...] Dr. Faulhaber discusses the concept of quantitation and in particular the Standard Uptake Value or SUV. Clinical PET relies on semi-quantitative methods which are based on the data acquired from the patient, and how that data is corrected for attenuation. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-003 Pitfalls & Artifacts of PET Imaging Part 2 http://www.clinicalpetcast.com/2009/11/25/cpc-003-pitfalls-artifacts-of-pet-imaging-part-2/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-003-pitfalls-artifacts-of-pet-imaging-part-2 http://www.clinicalpetcast.com/2009/11/25/cpc-003-pitfalls-artifacts-of-pet-imaging-part-2/#comments Thu, 26 Nov 2009 02:58:17 +0000 DirtyD http://www.clinicalpetcast.com/?p=65 Dr. Faulhaber continues this two-part session by examining specific regions of the body that can be quite confounding in the anatomic and physiologic variation. He begins with the head & neck, a very difficult area to interpret.

]]> http://www.clinicalpetcast.com/2009/11/25/cpc-003-pitfalls-artifacts-of-pet-imaging-part-2/feed/ 0 0:12:56 Dr. Faulhaber continues this two-part session by examining specific regions of the body that can be quite confounding in the anatomic and physiologic variation. He begins with the head & neck, a very difficult area to interpret. Dr. Faulhaber continues this two-part session by examining specific regions of the body that can be quite confounding in the anatomic and physiologic variation. He begins with the head & neck, a very difficult area to interpret. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-002 Pitfalls & Artifacts of PET Imaging Part 1 http://www.clinicalpetcast.com/2009/11/10/cpc-002-pitfalls-artifacts-of-pet-imaging-part-1/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-002-pitfalls-artifacts-of-pet-imaging-part-1 http://www.clinicalpetcast.com/2009/11/10/cpc-002-pitfalls-artifacts-of-pet-imaging-part-1/#comments Tue, 10 Nov 2009 20:33:06 +0000 DirtyD http://www.clinicalpetcast.com/?p=61 Dr. Peter Faulhaber examines the normal distribution on a PET scan of FDG and what variables to consider.  FDG uptake may vary considerably depending on factors from the patient’s recent activity such as eating, exercise, and excretion.  He also examines the factors that influence uptake on vital organs.

]]> http://www.clinicalpetcast.com/2009/11/10/cpc-002-pitfalls-artifacts-of-pet-imaging-part-1/feed/ 0 0:16:07 Dr. Peter Faulhaber examines the normal distribution on a PET scan of FDG and what variables to consider. FDG uptake may vary considerably depending on factors from the patient’s recent activity such as eating, exercise, and excretion. He also e[...] Dr. Peter Faulhaber examines the normal distribution on a PET scan of FDG and what variables to consider. FDG uptake may vary considerably depending on factors from the patient’s recent activity such as eating, exercise, and excretion. He also examines the factors that influence uptake on vital organs. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no CPC-001 Intro to Clinical PET Cast http://www.clinicalpetcast.com/2009/10/29/cpc-001-intro-to-clinical-pet-cast/?utm_source=rss&utm_medium=rss&utm_campaign=cpc-001-intro-to-clinical-pet-cast http://www.clinicalpetcast.com/2009/10/29/cpc-001-intro-to-clinical-pet-cast/#comments Thu, 29 Oct 2009 15:07:34 +0000 DirtyD http://www.clinicalpetcast.com/?p=57 This podcast is the first in a series by Dr. Peter Faulhaber, a radiologist at University Hospitals in Cleveland, Ohio. Dr. Faulhaber offers his perspective on various issues of Positron Emission Tomography from a hands-on clinical-based practical approach, based on 30 years of experience.

]]> http://www.clinicalpetcast.com/2009/10/29/cpc-001-intro-to-clinical-pet-cast/feed/ 0 0:08:26 This podcast is the first in a series by Dr. Peter Faulhaber, a radiologist at University Hospitals in Cleveland, Ohio. Dr. Faulhaber offers his perspective on various issues of Positron Emission Tomography from a hands-on clinical-based practical a[...] This podcast is the first in a series by Dr. Peter Faulhaber, a radiologist at University Hospitals in Cleveland, Ohio. Dr. Faulhaber offers his perspective on various issues of Positron Emission Tomography from a hands-on clinical-based practical approach, based on 30 years of experience. radiology, medical, oncology, nuclear, imaging, radiological, CT, PET Peter Faulhaber, MD no no